Management ChangeApr 30, 2026, 04:38 PM
TFX Appoints Jason Weidman as President & CEO, Effective June 8
AI Summary
Teleflex (TFX) announced the appointment of Jason Weidman as its new President and Chief Executive Officer, effective June 8, 2026. Mr. Weidman, previously from Medtronic plc, brings over 25 years of medical technology experience and will replace interim CEO Stuart A. Randle, who remains on the Board. His compensation package includes a $1 million annual base salary, a 125% target annual cash bonus, a $7 million annual equity award target, and sign-on equity grants totaling $8 million. The company expressed confidence in Weidman's ability to lead its growth strategy following recent divestitures.
Key Highlights
- Jason Weidman appointed President and CEO of Teleflex (TFX), effective June 8, 2026.
- Mr. Weidman replaces interim President and CEO Stuart A. Randle, who will continue as a Board member.
- Mr. Weidman joins from Medtronic plc, where he held senior leadership roles for nearly two decades.
- His compensation includes an annual base salary of $1 million and a target annual cash bonus of 125%.
- He will receive an annual equity award target of $7 million, starting in 2027.
- Sign-on grants include $7 million in restricted stock and $1 million in stock options.
- Mr. Weidman is eligible for a cash payment of up to $800,000 to replace forfeited incentive compensation.
- Relocation benefits and reimbursement of certain legal fees are also included in his offer letter.